A Pilot Window of Opportunity Trial: FL-101 in Non-Metastatic Muscle Invasive Bladder Cancer
Latest Information Update: 23 Aug 2022
At a glance
- Drugs FL-101 (Primary)
- Indications Bladder cancer; Urogenital cancer
- Focus Therapeutic Use
- Sponsors Flame Biosciences
Most Recent Events
- 17 Aug 2022 Status changed from not yet recruiting to withdrawn prior to enrolment on sponsor's decision.
- 03 Jun 2022 New trial record